A California company may be taking some of the scare out the Ebola virus.

Successful treatment of Ebola patients in Atlanta should give hope to a patient at Kaiser South Sacramento who is being tested for the deadly virus.  

Should that person test positive, there is the drug called Z-Mapp.

It's was created by a company in San Diego called Mapp Biopharmaceutical.

And it turns out that the genes with Ebola-fighting antibodies are injected in young tobacco plants and harvested later for drug manufacturing when the plants mature.

Company officials seem to be shying away from media coverage, but CEO Kevin Whaley says attention should be focused now on patients in Africa.